Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy.
Li K, Liao N, Chen B, Zhang G, Wang Y, Guo L, Wei G, Jia M, Wen L, Ren C, Cao L, Mok H, Li C, Lin J, Chen X, Zhang Z, Hou T, Li M, Liu J, Balch CM, Liao N.
Li K, et al. Among authors: li c, li m.
Breast Cancer Res Treat. 2020 Sep;183(2):321-332. doi: 10.1007/s10549-020-05778-0. Epub 2020 Jul 7.
Breast Cancer Res Treat. 2020.
PMID: 32638235
Free PMC article.